WUSA Channel 9 noted yesterday that Cambridge’s IES Life Science is partnering with the University of Maryland to develop the patented test for severe cases of COVID, which will be administered via nasal swabs, like the majority of the standard COVID tests, once a patient has tested positive.
Read the full story here
Write a Letter to the Editor on this Article
We encourage readers to offer their point of view on this article by submitting the following form. Editing is sometimes necessary and is done at the discretion of the editorial staff.